Race and survival of men after docetaxel-based treatment for mCRPC

A new paper in the Journal of Clinical Oncology has just reported that the overall survival (OS) of black and white men diagnosed with metastatic castration-resistant prostate cancer (mCRPC) seems to be near to identical after treatment with docetaxel or a docetaxel-containing regimen. … READ MORE …

Risk for prostate cancer among black males in England

A newly published article in the British Medical Journal has shown that black males in England are twice as likely to be diagnosed with prostate cancer as white males, and are twice as likely to die of prostate cancer too. … READ MORE …

Is race a factor in exercise and prostate cancer prevention?

We have known for some time that regular exercise may lower risk for prostate cancer. Indeed, a study by Clarke and Whittemore published in 2000 suggested that men who take little to no exercise may be 1.7 times more likely to be diagnosed with prostate cancer than those who exercise with a degree of regularity. … READ MORE …

White blood cell density and risk for prostate cancer

A recent Japanese paper has suggested that a low white blood cell (neutrophil) count may be an independent predictor of risk for a positive biopsy and a diagnosis of prostate cancer. … READ MORE …

The relative aggressiveness of prostate cancer in black and white patients

A newly published article, available on-line in the journal Prostate Cancer and Prostatic Diseases, shows that tissues from prostate biopsies from black men express higher levels of biomarkers for aggressive disease than do tissues from prostate biopsies taken from white men. … READ MORE …